AG
EBS icon

Aperio Group’s Emergent Biosolutions EBS Stock Holding History

Aperio Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2.2M Sell
24,560
-8,913
-27% -$818K 0.01% 1192
2020
Q3 		$3.46M Buy
33,473
+9,684
+41% +$1.04M 0.01% 880
2020
Q2 		$1.88M Buy
23,789
+1,190
+5% +$88.7K 0.01% 1137
2020
Q1 		$1.31M Buy
22,599
+1,788
+9% +$103K 0.01% 1190
2019
Q4 		$1.12M Buy
20,811
+1,226
+6% +$66.5K ﹤0.01% 1378
2019
Q3 		$1.02M Buy
19,585
+1,583
+9% +$73.7K ﹤0.01% 1380
2019
Q2 		$870K Sell
18,002
-1,508
-8% -$72.3K ﹤0.01% 1469
2019
Q1 		$986K Sell
19,510
-888
-4% -$52.4K ﹤0.01% 1380
2018
Q4 		$1.21M Buy
20,398
+4,405
+28% +$284K 0.01% 1206
2018
Q3 		$1.05M Buy
15,993
+822
+5% +$48K ﹤0.01% 1377
2018
Q2 		$766K Buy
15,171
+366
+2% +$19.1K ﹤0.01% 1524
2018
Q1 		$779K Buy
14,805
+1,497
+11% +$74.6K ﹤0.01% 1463
2017
Q4 		$618K Buy
13,308
+465
+4% +$19.6K ﹤0.01% 1606
2017
Q3 		$519K Buy
12,843
+1,199
+10% +$43.4K ﹤0.01% 1645
2017
Q2 		$395K Buy
11,644
+589
+5% +$18.2K ﹤0.01% 1758
2017
Q1 		$321K Sell
11,055
-592
-5% -$18K ﹤0.01% 1788
2016
Q4 		$382K Buy
11,647
+1,680
+17% +$50.4K ﹤0.01% 1670
2016
Q3 		$314K Sell
9,967
-1,358
-12% -$39.5K ﹤0.01% 1687
2016
Q2 		$318K Buy
11,325
+783
+7% +$30.7K ﹤0.01% 1636
2016
Q1 		$383K Buy
10,542
+2,154
+26% +$76.1K ﹤0.01% 1503
2015
Q4 		$336K Buy
8,388
+1,090
+15% +$38K ﹤0.01% 1546
2015
Q3 		$208K Buy
7,298
+981
+16% +$32.3K ﹤0.01% 1754
2015
Q2 		$208K Buy
+6,317
New +$196K ﹤0.01% 1838

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aperio Group's EBS Position: Q4 2020 in Review

Aperio Group reduced its Emergent Biosolutions (EBS) stake by 27% in Q4 2020, selling an estimated $818K and leaving 24,560 shares worth $2.2M. The position accounts for 0.01% of the portfolio, ranked #1192.

Aperio Group first reported a position in EBS in Q2 2015 and has held it in 23 quarters since. The position peaked at $3.46M in Q3 2020. 353 funds tracked by Wall St. Rank hold EBS as of Q4 2020.

  • Aperio Group held 24,560 shares of Emergent Biosolutions worth $2.2M as of Q4 2020.
  • Aperio Group sold 8,913 Emergent Biosolutions shares in Q4 2020, an estimated $818K.
  • Emergent Biosolutions made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1192 holding.
  • Aperio Group first reported a position in Emergent Biosolutions in Q2 2015 and has held it in 23 quarters since.
  • Aperio Group's Emergent Biosolutions position peaked at $3.46M in Q3 2020.
  • 353 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.